Noncompaction cardiomyopathy natural history

Jump to navigation Jump to search

Noncompaction Cardiomyopathy Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification & Nomenclature

Pathophysiology

Genetics
Embryology
Histology
Left Ventricular Dysfunction
Arrhythmias
Thromboembolism
Neuromuscular Disorders

Epidemiology & Demographics

Screening

Natural History, Complications & Prognosis

Differentiating Noncompaction Cardiomyopathy from other Diseases

Diagnosis

History & Symptoms

Physical Examination

Laboratory Studies

Genetic Testing

Electrocardiogram

Holter Monitoring

Chest X Ray

MRI

CT

Echocardiography

Biopsy

Treatment

Medical Therapy

Surgery

Noncompaction cardiomyopathy natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Noncompaction cardiomyopathy natural history

CDC on Noncompaction cardiomyopathy natural history

Noncompaction cardiomyopathy natural history in the news

Blogs on Noncompaction cardiomyopathy natural history

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Noncompaction cardiomyopathy natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The presence of NCC is associated with congestive heart failure and disesae in other organs.

Complications and Associated Involvement of Other Organs

Cardiac Disease

Neurologic Complications

Associated Genetic Disorders

Prognosis

In so far as noncompaction cardiomyopathy is a recently described entity, its association with long term clinical outcomes is not known. In a 2005 study [1] which documented the long term follow up of 34 patients who were symptomatic with NCC, 35% had died at the age of 42 +/- 40 months. 12% of the patients required cardiac transplantation due to heart failure.

The prognosis associated with NCC may be better than that reported in this article because only symptomatic patients were included in the aforementioned study. Genetic testing reveals that there are patients with lesser degrees of symptoms, and the prognosis in these patients has not been well defined.

References

  1. Oechslin, Erwin; Jenni, Rolf (2005). "Non-compaction of the Left Ventricular Myocardium - From Clinical Observation to the Discovery of a New Disease" (webpage).

Template:WH Template:WS